Peter Rossing
Impact in
- Nephrology top 0.01%
- Chronic Kidney Disease and Diabetes
- Endocrinology, Diabetes and Metabolism top 0.01%
- Diabetes Treatment and Management
- Diabetes Management and Research
- Hormonal Regulation and Hypertension
Papers in
-
- Diabetes Treatment and Management 177
- Hormonal Regulation and Hypertension 71
- Diabetes Management and Research 50
-
- Blood Pressure and Hypertension Studies 71
- Cardiovascular Function and Risk Factors 47
- Co-authors
- Lise Tarnow (114 shared papers)Hans‐Henrik Parving (108 shared papers)Melanie J. Davies (11 shared papers)John B. Buse (11 shared papers)Απόστολος Τσάπας (7 shared papers)Geltrude Mingrone (7 shared papers)Hiddo J.L. Heerspink (107 shared papers)Frederik Persson (116 shared papers)
- Journals
- Diabetes Care (67 papers)Nephrology Dialysis Transplantation (55 papers)Diabetes (48 papers)Diabetologia (44 papers)Kidney International (37 papers)
- Partner nations
- DenmarkUnited StatesUnited Kingdom
In The Last Decade
Peter Rossing
733 papers receiving 42.3k citations
Peter Rossing's Hit Papers
Peers
Comparison fields: 5 of 160
- Nephrology 9.9k
- Endocrinology, Diabetes and Metabolism 19.2k
- Cardiology and Cardiovascular Medicine 7.8k
- Clinical Biochemistry 1.6k
- Pharmacology 2.4k
Countries citing papers authored by Peter Rossing
This map shows the geographic impact of Peter Rossing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Rossing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Rossing more than expected).
Fields of papers citing papers by Peter Rossing
This network shows the impact of papers produced by Peter Rossing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Rossing. The network helps show where Peter Rossing may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Rossing, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 783 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Dapagliflozin in Patients with Chronic Kidney Disease Hit paper breakdown → | 2020 | 3296 |
| 2 | Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) Hit paper breakdown → | 2018 | 2744 |
| 3 | Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes Hit paper breakdown → | 2020 | 1640 |
| 4 | Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) Hit paper breakdown → | 2018 | 1138 |
| 5 | Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) Hit paper breakdown → | 2022 | 1051 |
| 6 | Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis Hit paper breakdown → | 2012 | 1014 |
| 7 | 2019 Update to: Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) Hit paper breakdown → | 2019 | 869 |
| 8 | Diabetic kidney disease Hit paper breakdown → | 2015 | 845 |
| 9 | Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes Hit paper breakdown → | 2024 | 830 |
| 10 | KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease Hit paper breakdown → | 2022 | 702 |
| 11 | Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis Hit paper breakdown → | 2021 | 642 |
| 12 | Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) Hit paper breakdown → | 2022 | 579 |
| 13 | Effect of Finerenone on Albuminuria in Patients With Diabetic Nephropathy Hit paper breakdown → | 2015 | 527 |
| 14 | Diabetes and Hypertension: A Position Statement by the American Diabetes Association Hit paper breakdown → | 2017 | 484 |
| 15 | Diabetes Management in Chronic Kidney Disease: A Consensus Report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO) Hit paper breakdown → | 2022 | 438 |
| 16 | Effects of dapagliflozin on major adverse kidney and cardiovascular events in patients with diabetic and non-diabetic chronic kidney disease: a prespecified analysis from the DAPA-CKD trial Hit paper breakdown → | 2020 | 372 |
| 17 | 1996 | 361 | |
| 18 | 2019 update to: Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) Hit paper breakdown → | 2019 | 360 |
| 19 | Years of life gained by multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: 21 years follow-up on the Steno-2 randomised trial Hit paper breakdown → | 2016 | 346 |
| 20 | 2012 | 329 |
About Peter Rossing
Peter Rossing is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine, Nephrology, Molecular Biology and Surgery, having authored 783 papers that have together received 43.6k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (177 papers), Chronic Kidney Disease and Diabetes (155 papers), Blood Pressure and Hypertension Studies (71 papers), Hormonal Regulation and Hypertension (71 papers), Diabetes Management and Research (50 papers), Cardiovascular Function and Risk Factors (47 papers), Pancreatic function and diabetes (33 papers) and Metabolism, Diabetes, and Cancer (29 papers). The work is most often cited by research in Nephrology (9.9k citations), Endocrinology, Diabetes and Metabolism (19.2k citations), Cardiology and Cardiovascular Medicine (7.8k citations), Clinical Biochemistry (1.6k citations) and Pharmacology (2.4k citations). Peter Rossing has collaborated with scholars based in Denmark, United States and United Kingdom. Frequent co-authors include Lise Tarnow, Hans‐Henrik Parving, Melanie J. Davies, John B. Buse, Απόστολος Τσάπας, Geltrude Mingrone, Hiddo J.L. Heerspink, Frederik Persson, Deborah J. Wexler and David A. D’Alessio. Their work appears in journals such as Diabetes Care, Nephrology Dialysis Transplantation, Diabetes, Diabetologia and Kidney International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.